Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, Feb. 15, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2023 financial results and provided a corporate update.

View Full Press Release